Treatment with the cell-permeable cysteine precursor NAC restored neuronal glutathione levels and prevented neuronal death, supporting the hypothesis that impaired cysteine uptake in EAAT3-depleted neurons underlies the higher susceptibility to oxidative damage after stroke. The gene discussed is SLC1A1; the disease is Stroke.